// App-Quantinova.ai

: Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Hiroaki Shimizu

Principal Investigators

  • Nahoko Hatsumi

  • Satoru Takada

  • Takuma Ishizaki

  • Akihiko Yokohama

  • Takayuki Saitoh

  • Toru Sakura

  • Hiroshi Handa

Medical Centers

  • Department of Dermatology, Gunma University Hospital, Gunma, Japan

  • Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan

  • Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan

  • Department of Dermatology, Gunma University Hospital, Gunma, Japan

  • Blood Transfusion Service, Gunma University School of Med., Maebashi, Japan

  • Graduate School of Medicine, Gunma University, Maebashi, Gunma, Japan

  • Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan

  • Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A